期刊文献+

姜黄素对结肠癌细胞化疗耐药的抑制作用研究 被引量:1

The Inhibitory Effect of Curcumin on Chemoresistance of Colon Cancer Cells
下载PDF
导出
摘要 目的:探讨姜黄素对耐5氟尿嘧啶和奥沙利铂的结肠癌细胞的抑制作用。方法:大剂量冲击方法联合剂量梯度法建立结肠癌耐5氟尿嘧啶和奥沙利铂的细胞,Real-time PCR方法检测耐药细胞的干性基因表达情况,MTT方法检测姜黄素对耐药细胞的增殖抑制作用。结果:成功建立结肠癌耐5氟尿嘧啶和奥沙利铂细胞,其干细胞相关基因如CD133、CD24、ALDH1、OCT-4、SOX-2和Nanog1表达上调,提示其干性增高可能是结肠癌耐药的一个主要因素,姜黄素对两种耐药结肠癌细胞的增殖具有明显抑制作用,且能抑制耐药细胞干细胞标志物的表达。结论:姜黄素可有效抑制耐药结肠癌细胞,有望成为结肠癌治疗的辅助性药物。 Objective To investigate the inhibitory effect of curcumin on colon cancer cells resistant to 5-fluorouracil and oxaliplatin.Methods 5-fluorouracil and oxaliplatin resistant colon cancer cells lines were established by high-dose shock combined with dose gradient method.The expression of stemness genes was detected by real-time PCR,and the proliferation inhibition of curcumin on drug-resistant cell lines was detected by MTT method.Results 5-fluorouracil-resistant and oxaliplatin resistant colon cancer cell lines were successfully established,and the stem cell related genes were upregulated such as CD133,CD24,ALDH1,OCT-4,SOX-2 and Nanog1,suggesting that the increased stemness may be a major factor of drug resistance.Curcumin can effectively inhibit the proliferation of drug-resistant cell lines and inhibit the expression of stem cell markers of drug-resistant cells.Conclusion Curcumin can effectively inhibit drug-resistant colon cancer cells,and is expected to become an adjuvant drug in the treatment of colon cancer.
作者 李尤玲 雷飞飞 樊旭 朱敏 郗雪艳 李刚 LI You-ling;LEI Fei-fei;FAN Xu;ZHU Min;XI Xue-yan;LI Gang(Renmin Hospital;Institute of Basic Medical Science,Hubei University of Medicine,Shiyan,Hubei,442000,China)
出处 《湖北医药学院学报》 CAS 2021年第4期338-341,348,共5页 Journal of Hubei University of Medicine
基金 湖北省教育厅重点项目(D20172103) 湖北省卫生健康委面上项目(ZY2019M050)。
关键词 姜黄素 结肠癌 肿瘤干细胞 耐药 Curcumin Colon cancer Cancer stem cells Drug resistance
  • 相关文献

参考文献2

二级参考文献35

  • 1George F. VANDE WOUDE.HGF/SF-Met signaling in tumor progression[J].Cell Research,2005,15(1):49-51. 被引量:25
  • 2Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet, 2006,7:606-619.
  • 3Wong KK, Engelman JA, Cantley LC. Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev, 2010,20:87-90.
  • 4Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PICK3CA gene in human cancers. Science, 2004,304:554.
  • 5Li J, Yen C, Liaw 0, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997,275:1943-1947.
  • 6Guertin DA, Sabatini OM. Defining the role of mTOR in cancer. Cancer Cell, 2007,12:9-22.
  • 7Sabatini OM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer, 2006,6:729-734.
  • 8Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev, 2004,18:1926-1945.
  • 9Dowling RJ, Topisirovic I, Alain T, et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science, 2010,328: 1172-1176.
  • 10Guertin DA, Sabatini OM. The pharmacology of mTOR inhibition. Sci Signal, 2009,2:pe24.

共引文献9

同被引文献23

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部